Dermatology Focus Almirall specializes in medical dermatology with a broad portfolio including psoriasis, actinic keratosis, atopic dermatitis and acne, presenting opportunities to cross-sell dermatology-focused solutions to global networks and leverage partnerships in skin health.

Global Reach With operations spanning over 100 countries across five continents and 15 affiliates, Almirall offers a scalable platform for international distribution, regional launches, and partner collaborations that can extend sales channels and market access.

R&D & Innovation Active investment in R&D and ongoing collaborations (e.g., Evotec dermatology alliance) indicate a readiness to adopt and co-develop innovative therapies, enabling BD opportunities around collaboration deals, licensing, or joint ventures.

Regulatory & Submissions Recent EMA activity for paediatric registration of Lebrikizumab signals appetite for regulatory approvals and expanded indications, creating potential for strategic partnerships in pediatrics and late-stage clinical programs.

Financial Footing Revenue in the mid-range of hundreds of millions and a dedicated funding level suggest capacity for incremental partnerships, co-marketing arrangements, or value-added distribution deals to accelerate growth without over-leveraging.